Prescription patterns of psychotropics in patients receiving synthetic glucocorticoids.

Acta Psychiatrica Scandinavica
T YatomiHiroyuki Uchida

Abstract

Synthetic glucocorticoids cause various psychiatric symptoms. Prescription of psychotropic drugs could be considered to be a proxy for manifestation of psychiatric symptoms. The aim of this study was to investigate the prescriptions of psychotropics in outpatients receiving synthetic glucocorticoids. We used the claims sampling data during January 2015 from the National Database of Health Insurance Claims and Specific Health Checkups of Japan made by the Ministry of Health, Labor, and Welfare in Japan. We compared the prescription rates of psychotropics between outpatients receiving oral synthetic glucocorticoids and age- and sex-matched controls and the prescription rates of psychotropics among the eight dosage groups of synthetic glucocorticoids by chi-squared test, and chlorpromazine/imipramine/diazepam equivalent doses (or daily defined doses) of respective psychotropics among these groups using Welch's t-test. Synthetic glucocorticoids were prescribed to 3.1% (n = 18 122) of 581 990 patients. The prescription rates of psychotropics were significantly higher among the synthetic glucocorticoid recipients than among the non-recipients: antipsychotics, 1.8% (n = 321) vs. 1.1% (n = 201) (P = 1.4 × 10-7 ); antidepressants, 4.0% ...Continue Reading

References

Sep 1, 1972·Clinical Pharmacology and Therapeutics
Jan 19, 2002·Journal of Clinical Psychopharmacology·E Sherwood BrownThomas J Carmody
Nov 24, 2004·Journal of Affective Disorders·E Sherwood BrownMichael Sargeant
Oct 21, 2005·The New England Journal of Medicine·Turk Rhen, John A Cidlowski
Oct 14, 2006·Mayo Clinic Proceedings·Thomas P Warrington, J Michael Bostwick
Sep 18, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Laurence FardetAntoine Flahault
Jul 2, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Hiroyuki UchidaMasayuki Tomita
Jan 30, 2009·Psychiatry and Clinical Neurosciences·Hiroyuki UchidaHaruo Kashima
Nov 13, 2009·Annals of the New York Academy of Sciences·E Sherwood Brown
Jan 8, 2010·International Journal of Geriatric Psychiatry·Kenichi TsunodaHaruo Kashima
Mar 20, 2012·Psychosomatics·Amelia N DubovskyLloyd Axelrod
Jul 6, 2012·The American Journal of Psychiatry·Laurence FardetIrwin Nazareth
Oct 2, 2014·The American Journal of Psychiatry·Lewis L JuddGagandeep Singh
Jan 21, 2015·Psychiatry and Clinical Neurosciences·Toshiya Inada, Ataru Inagaki
Nov 19, 2017·Journal of Affective Disorders·Mario F JuruenaAllan H Young
Feb 8, 2018·The Journal of Allergy and Clinical Immunology. in Practice·E Sherwood BrownTraci Holmes
Mar 6, 2018·The New England Journal of Medicine·Tricia McKeeverTimothy Harrison
Oct 27, 2018·Journal of the American Academy of Dermatology·Kevin R PatelJonathan I Silverberg
Jan 8, 2019·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·E Sherwood BrownTraci Holmes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

RN
Steven C Stoner, Beth Dubisar
AMB : revista da Associação Médica Brasileira
D Albuquerque Fortes, I Guz
Psychosomatics
R J Goldberg, L O Cullen
Geriatrics & Gerontology International
Kazumi AsanumaHidetada Sasaki
© 2021 Meta ULC. All rights reserved